How Lessons Learned from Oncology and Rheumatology Can Pave the Way for Biosimilar Success in Ophthalmology

 This session will explore current U.S. biosimilar

market trends and what they may suggest for future use in new therapeutic

areas, including the next major market — ophthalmology. The presentation will

include: 

· A review of biosimilar uptake trends

in oncology and rheumatology and discussion of what these trends may suggest

for other therapeutic areas 

· A review of the ophthalmology

treatment landscape for retinal disorders and biosimilars currently in

development  

· Results of an original research study

with ophthalmologists assessing their understanding of biosimilars, interest in

prescribing, and potential objections to adoption 

Sonia T. Oskouei, Vice President Biosimilars, Cardinal Health